ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,374,000 | -46.2% | 1,882,768 | -33.7% | 0.03% | -43.5% |
| Q2 2022 | $2,553,000 | -51.0% | 2,837,800 | -18.8% | 0.05% | -45.2% |
| Q1 2022 | $5,206,000 | -31.3% | 3,493,800 | 0.0% | 0.08% | -13.4% |
| Q4 2021 | $7,582,000 | -25.4% | 3,493,800 | +22.3% | 0.10% | -13.4% |
| Q3 2021 | $10,167,000 | -15.7% | 2,856,000 | +36.0% | 0.11% | -8.2% |
| Q2 2021 | $12,054,000 | +10.6% | 2,100,000 | 0.0% | 0.12% | +19.6% |
| Q1 2021 | $10,899,000 | – | 2,100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |